Edgestream Partners’s United Therapeutics UTHR Stock Holding History

Edgestream Partners’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.97M	Buy	+9,178	New	+$5.17M	0.15%	245
2025 Q4	–	Sell	-2,234	Closed	-$937K	–	1148
2025 Q3	$937K	Buy	+2,234	New	+$751K	0.03%	641
2025 Q1	–	Sell	-7,117	Closed	-$2.51M	–	1088
2024 Q4	$2.51M	Buy	7,117 +2,696	+61%	+$991K	0.11%	348
2024 Q3	$1.58M	Buy	+4,421	New	+$1.49M	0.07%	467
2024 Q2	–	Sell	-2,558	Closed	-$588K	–	1049
2024 Q1	$588K	Sell	2,558 -2,614	-51%	-$590K	0.03%	608
2023 Q4	$1.14M	Sell	5,172 -5,259	-50%	-$1.21M	0.08%	404
2023 Q3	$2.36M	Buy	10,431 +6,370	+157%	+$1.47M	0.19%	150
2023 Q2	$896K	Buy	+4,061	New	+$900K	0.08%	380
2022 Q3	–	Sell	-3,820	Closed	-$900K	–	618
2022 Q2	$900K	Buy	+3,820	New	+$777K	0.07%	341
2021 Q4	–	Sell	-4,790	Closed	-$884K	–	588
2021 Q3	$884K	Sell	4,790 -5,141	-52%	-$1.01M	0.05%	332
2021 Q2	$1.78M	Buy	+9,931	New	+$1.89M	0.11%	234

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Edgestream Partners's UTHR Position: Q2 2026 in Review

Edgestream Partners opened a new position in United Therapeutics (UTHR) in Q2 2026: 9,178 shares worth $4.97M. The stake represents 0.15% of the portfolio and ranks #245 among its holdings. This is a return to the name: Edgestream Partners previously reported a position in UTHR as recently as Q3 2025.

Edgestream Partners first reported a position in UTHR in Q2 2021 and has held it in 11 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Edgestream Partners held 9,178 shares of United Therapeutics worth $4.97M as of Q2 2026.
United Therapeutics was a new Edgestream Partners position in Q2 2026.
United Therapeutics made up 0.15% of Edgestream Partners's portfolio in Q2 2026, its #245 holding.
Edgestream Partners first reported a position in United Therapeutics in Q2 2021 and has held it in 11 quarters since.
880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.